Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study

Clinical Nephrology

Volumn 75, Issue 6, 2011, Pages 518-523

  Di Biagio, A ^a   Rosso, R ^a   Vitale, F ^a   Cardinale, F ^a   Sormani, M P ^b   Secondo, G ^a   Di Stefano, L ^a   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

AIDS; Glomerular filtration rate; HCV; HIV 1; Indinavir; Proteinuria; Tenofovir

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CREATININE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DISEASE DURATION; DRUG EXPOSURE; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROSPECTIVE STUDY; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; ITALY; MIDDLE AGED; NONPARAMETRIC TEST; STATISTICAL MODEL; SUBSTANCE ABUSE; TIME; URINE; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; ITALY; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS; STATISTICS, NONPARAMETRIC; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 79960934322     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75518     Document Type: Article

References (21)

1. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV medicine association of the infectious disease society of America. Clin Infect Dis. 2005; 40: 1559-1585.
2. Röling J, Schmid H, Fishereder M, Draenert R, Goebel FD. HIV-associated renal disease and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis. 2006; 42: 1488-1495.
3. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicentric AIDS cohort study. Arch Intern Med. 2005; 165: 1179-1184.
4. Seaberg EC, Munoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Multicenter AIDS Cohort Study. Association between highly active antiretroviral therapy and hypertension in a large cohort of menfollowed from 1984 to 2003. AIDS. 2005; 19: 953-960.
5. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinemia and vasculitis: immune complex relations. Lancet Infect Dis. 2005; 5: 227-236.
6. Tashima KT, Horowitz JD, Rosen S. Indinavir nephropathy. N Engl J Med. 1997; 336: 138-140.
7. Szczech LA, Edwards LJ, Sanders LL, van der Horst C, Bartlett JA, Heald AE, Svetkey LP. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol. 2002; 57: 336-341.
8. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug Induced Fanconi's syndrome.AmJ Kidney Dis. 2003; 41: 292-309.
9. George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS. 2010; 24: 387-394.
10. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999; 130: 461-470.
12. Izzedine H, Deray G. The nephrologist in the HAART era. AIDS. 2007; 21: 409-421.
13. Luke DR, Sarnoski TP, Dennis S. Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome. Clin Nephrol. 1992; 38: 69-74.
14. Fulop T, Olivier J, Meador RS, Hall J, Islam N, Mena L, Henderson H, Schmidt DW. Screening for chronic kidney disease in the ambulatory HIV population. Clin Nephrol. 2010; 73: 190-196.
15. Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, McGwin G Jr. HIV Outpatient Study Group. Factors associated with chronic renal fail-ure in HIV-infected ambulatory patients. AIDS. 2004; 18: 2171-2178.
16. Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD. Chronic renal failure among HIVinfected patients. AIDS. 2007; 21: 1119-1127.
17. Sorlì ML, Guelar A, Montero M, Gonzalez A, Rodriguez E, Knobel H. Chronic kidney disease prevalence and risk factors among human immunodeficiency virus-infected patients. JAIDS. 2008; 48: 50.
18. Déti EK, Thiébaut R, Bonnet F, Lawson-Ayayi S, Dupon M, Neau D, Pellegrin JL, Malvy D, Tchamgoué S, Dabis F, Morlat P; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. HIVMed. 2010; 11: 308-317.
19. Izzedine H, Sene D, Cacoub P, Jansen H, Camous L, Brocheriou I, Bourry E, Deray G. Kidney diseases in HIV/HCV-co-infected patients. AIDS. 2009; 23: 1219-1226.
20. Chidambaram M, Stigant CE, Sugar LM, Ramesh Prasad GV. Clin Nephrol. 2002; 57: 154-157.
21. Crowely ST. Prevalence of persistent asymptomatic proteinuria in HIV-infected outpatients and lack of correlation with viral load. Clin Nephrol. 2001; 55: 1-6.